Bottom line
FBT vs FBTAX: the short answer
FBT (First Trust NYSE Arca Biotechnology Index Fund) and FBTAX (Fidelity Advisor Biotechnology Fund) are both etfs.
But FBTAX is far broader, holding 129 positions to 32 for FBT, so beyond the top names it adds exposure FBT doesn't have.
FBT is cheaper at 0.55% vs 0.94% — a difference of $39 a year per $10,000 invested.
Over five years, FBTAX returned +6.4% a year vs +4.3% for FBT (reporting dates differ).
Updated Nov 19, 2026
FBT vs FBTAX side by side
| FBT | FBTAX | |
|---|---|---|
| Type | ETF | Mutual fund |
| Fund family | First Trust | Fidelity |
| Category | Technology Sector | Technology Sector |
| Expense ratio | 0.55% | 0.94% |
| Annual cost per $10k | $55 | $94 |
| 10-yr cost on $10k (prospectus) | — | $1,663 |
| Max front load | None | — |
| 12b-1 fee | 0% | 0.25% |
| 1-yr return | +24.1% | +31.5% |
| 5-yr return (annualized) | +4.3% | +6.4% |
| 10-yr return (annualized) | +6.3% | +7.7% |
| Best quarter | +27.8% | +30.3% |
| Worst quarter | −22.5% | −27.8% |
| Net assets (fund) | $2.8B | $2.2B |
| Number of holdings | 32 | 129 |
| Portfolio turnover | 37% | 54% |
| Returns as of | Dec 31, 2025 | Sep 30, 2026 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | FBT | FBTAX | Difference |
|---|---|---|---|
| 2025 | +24.1% | +39.6% | −15.5% |
| 2024 | +5.8% | +5.3% | +0.4% |
| 2023 | +2.3% | +10.7% | −8.4% |
| 2022 | −4.6% | −8.0% | +3.4% |
| 2021 | −3.6% | −3.6% | −0.1% |
| 2020 | +12.9% | +32.2% | −19.2% |
| 2019 | +19.8% | +25.7% | −5.9% |
| 2018 | −0.2% | −3.8% | +3.6% |
| 2017 | +37.0% | +25.8% | +11.2% |
| 2016 | −19.6% | −23.6% | +4.0% |
Source: Fund prospectus bar charts
Holdings overlap
6 of FBT's top 25 holdings also appear in FBTAX's top 25.
| Holding | FBT | FBTAX |
|---|---|---|
| Natera Inc | 3.79% | 1.43% |
| Biogen Inc | 3.37% | 2.71% |
| Argenx Se | 3.13% | 3.00% |
| Vertex Pharmaceuticals Inc | 3.07% | 1.39% |
| Amgen Inc | 2.78% | 2.37% |
| Alnylam Pharmaceuticals Inc | 2.52% | 3.62% |
Source: SEC Form N-PORT
FBT top 10
- Corcept Therapeutics Inc — 5.60%
- Neogenomics Inc — 5.12%
- Veracyte Inc — 5.10%
- Bruker Corp — 4.32%
- Alkermes Plc — 4.24%
- Illumina Inc — 3.92%
- Krystal Biotech Inc — 3.87%
- Natera Inc — 3.79%
- Axsome Therapeutics Inc — 3.71%
- Neurocrine Biosciences Inc — 3.53%
FBTAX top 10
- Abbvie Inc — 14.71%
- Gilead Sciences Inc — 5.70%
- Spyre Therapeutics Inc — 3.83%
- Alnylam Pharmaceuticals Inc — 3.62%
- Dianthus Therapeutics Inc — 3.55%
- Cogent Biosciences Inc — 3.25%
- Oruka Therapeutics Inc — 3.24%
- Insmed Inc — 3.05%
- Revolution Medicines Inc — 3.00%
- Argenx Se — 3.00%
FAQ
What is the difference between FBT and FBTAX?
Which is cheaper, FBT or FBTAX?
Should I own both FBT and FBTAX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.